ADDvise Group B (ADDV-B) - Total Liabilities
Based on the latest financial reports, ADDvise Group B (ADDV-B) has total liabilities worth Skr1.81 Billion SEK (≈ $194.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. For the complete balance sheet picture, see total assets of ADDvise Group B.
ADDvise Group B - Total Liabilities Trend (2007–2024)
This chart illustrates how ADDvise Group B's total liabilities have evolved over time, based on quarterly financial data. See ADDvise Group B (ADDV-B) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
ADDvise Group B Competitors by Total Liabilities
The table below lists competitors of ADDvise Group B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Woongjin Co Ltd
KO:016880
|
Korea | ₩4.82 Trillion |
|
Alterity Therapeutics Ltd
AU:ATH
|
Australia | AU$2.65 Million |
|
Riber S.A
PA:ALRIB
|
France | €27.29 Million |
|
Pulse Seismic Inc
TO:PSD
|
Canada | CA$6.16 Million |
|
Sunflow Sustain
TA:SNFL
|
Israel | ILA551.59 Million |
|
Kleannara Co Ltd
KO:004545
|
Korea | ₩466.61 Billion |
|
Yuen Chang Stainless Steel Co Ltd
TW:2069
|
Taiwan | NT$4.86 Billion |
|
ZHEJIANG SHIBAO H YC 1
F:W4K1
|
Germany | €1.65 Billion |
Liability Composition Analysis (2007–2024)
This chart breaks down ADDvise Group B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. Check how resilient are ADDvise Group B's assets to evaluate the company's liquid asset resilience ratio.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.93 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.63 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.62 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ADDvise Group B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ADDvise Group B (2007–2024)
The table below shows the annual total liabilities of ADDvise Group B from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr2.61 Billion ≈ $281.06 Million |
-2.34% |
| 2023-12-31 | Skr2.67 Billion ≈ $287.79 Million |
+81.19% |
| 2022-12-31 | Skr1.48 Billion ≈ $158.83 Million |
+79.52% |
| 2021-12-31 | Skr822.17 Million ≈ $88.48 Million |
+222.81% |
| 2020-12-31 | Skr254.69 Million ≈ $27.41 Million |
-7.79% |
| 2019-12-31 | Skr276.23 Million ≈ $29.73 Million |
+15.18% |
| 2018-12-31 | Skr239.81 Million ≈ $25.81 Million |
+4.86% |
| 2017-12-31 | Skr228.69 Million ≈ $24.61 Million |
+28.17% |
| 2016-12-31 | Skr178.43 Million ≈ $19.20 Million |
+43.09% |
| 2015-12-31 | Skr124.70 Million ≈ $13.42 Million |
-17.78% |
| 2014-12-31 | Skr151.67 Million ≈ $16.32 Million |
+98.74% |
| 2013-12-31 | Skr76.32 Million ≈ $8.21 Million |
+31.13% |
| 2012-12-31 | Skr58.20 Million ≈ $6.26 Million |
+310.71% |
| 2011-12-31 | Skr14.17 Million ≈ $1.52 Million |
-17.69% |
| 2010-12-31 | Skr17.21 Million ≈ $1.85 Million |
+62.48% |
| 2008-12-31 | Skr10.60 Million ≈ $1.14 Million |
+25.07% |
| 2007-12-31 | Skr8.47 Million ≈ $911.61K |
-- |
About ADDvise Group B
ADDvise Group AB (publ) supplies medical devices, equipment, and consumables to public and private laboratories and research facilities, healthcare, and pharmaceuticals in North America, Europe, South America, Sweden, and internationally. The company provides laboratory furniture, protective ventilation systems, climate-controlled clean rooms, and laboratory equipment; and develops and supplies m… Read more